HOME >> BIOLOGY >> NEWS
New imaging technique developed to identify breast cancer

Researchers at Johns Hopkins have for the first time used a chemical marker detected by proton magnetic resonance spectroscopic imaging (MRSI) to successfully diagnose breast cancer. The diagnostic technique produces pictures of choline within breast tumors.

In the study, researchers from the Russell H. Morgan Department of Radiology and Radiological Science at Hopkins demonstrated that choline signals analyzed by MRI were significantly elevated in malignant tumors in 15 of 18 patients studied. Three of the cases could not be included because of technical failures such as patient movement or computer failure during the scanning procedure.

The results are published in the December-January issue of the Journal of Magnetic Resonance Imaging.

Scientists have long known that cancers contain elevated levels of choline, a product of membrane synthesis, but the Hopkins study is believed to be the first to demonstrate its value in accurately identifying breast tumors.

MRSI of the breast does not appear likely to be cost-effective as a routine screening tool for breast cancer, but may prove to be a viable, noninvasive alternative to biopsy in cases with positive mammography or clinical breast exam results, says Michael A. Jacobs, Ph.D., the lead researcher for the Hopkins study. "What MRSI does provide is information about the molecular environment of breast tumors, which also may be useful in designing therapeutic interventions for patients."

Proton magnetic resonance imaging uses the water content in tissue to produce images by measuring signals emitted after subjecting the tissue to high magnetic fields, but provides no information on the chemical or molecular aspects of the tissue being imaged. Combining proton MRI with spectroscopy allows the scientists to differentiate intracellular components of the cell and signals emitted by certain biochemicals, such as choline.

In the study, 15 patients who had been referred
'"/>

Contact: Gary Stephenson
gstephenson@jhmi.edu
410-955-5384
Johns Hopkins Medical Institutions
1-Mar-2004


Page: 1 2

Related biology news :

1. New imaging technology at Joslin shown to detect early signs of type 1 diabetes
2. Trojan Horses, xenon imaging and remote controlled genes
3. Small animal imaging gives cancer clues
4. Computer imaging of Archeopteryx skull suggests this dinosaur-bird link could fly
5. Innovative efforts target epigenetics, molecular imaging
6. Carnegie Mellon U. imaging study reveals sex-based differences that persist as mice enter adulthood
7. Whole body imaging allows better understanding of the immune system
8. 3-D micro-imaging technology licensed to Carl Zeiss Jena
9. SPECT imaging shows promise for accurate, early diagnosis of Alzheimers
10. Carnegie Mellon enhances Quantum Dot Corp. technology for long-term, live-animal imaging
11. Combining various magnetic resonance imaging techniques may help improve breast cancer detection

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2018)... ... August 16, 2018 , ... ... epigenetics service provider based in Gent, Belgium. NXT-Dx provides a broad variety ... using pyrosequencing or Next-Generation Sequencing and Illumina’s Infinium Methylation EPIC array. These ...
(Date:8/17/2018)... (PRWEB) , ... August 16, 2018 , ... ... the world’s first private cord blood bank to separate and store stem cells ... Law Center, and Brian Sheehy, M.D. M.A. C.F.A., Founder and Managing Partner IsZo ...
(Date:8/14/2018)... ST. LOUIS (PRWEB) , ... August 13, 2018 ... ... seekers to meet potential employers and explore opportunities with multiple health systems at ... additional travel. Virtual career fairs offer another, more efficient option for healthcare providers ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... ... ... Cognition Corporation ®, a software company specializing in medical device compliance and ... Ryan Ward, Director of Engineering at Zimmer Biomet, has been announced as a speaker ... Zimmer Biomet for almost 15 years, Mr. Ward will focus his talk about how ...
(Date:8/29/2018)... ... 2018 , ... CEO and founder of VetStem Biopharma, Dr. ... an allogeneic (donor derived) stem cell product for osteoarthritis in canines at the ... He is also the organizer of Breakout Session 4: Practitioner Primer on FDA ...
(Date:8/29/2018)... SANTA BARBARA, Calif. (PRWEB) , ... August 28, 2018 , ... ... process optimization firm for the life sciences and healthcare industries, announces that Manu Vohra ... CA on August 30th. , What: “How to Implement Box for GxP in ...
(Date:8/26/2018)... Korea (PRWEB) , ... August 24, 2018 , ... ... paper on that stem cell-derived exosomes dramatically relieves atopic dermatitis and inhibits a ... , According to the paper, the symptoms of mice having severe atopic ...
Breaking Biology Technology:
Cached News: